These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 9050073)

  • 1. Effects of mecamylamine on spontaneous EEG and performance in smokers and non-smokers.
    Pickworth WB; Fant RV; Butschky MF; Henningfield JE
    Pharmacol Biochem Behav; 1997 Feb; 56(2):181-7. PubMed ID: 9050073
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acute effects of nicotine and mecamylamine on tobacco withdrawal symptoms, cigarette reward and ad lib smoking.
    Rose JE; Behm FM; Westman EC
    Pharmacol Biochem Behav; 2001 Feb; 68(2):187-97. PubMed ID: 11267622
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combined nicotinic and muscarinic blockade in elderly normal volunteers: cognitive, behavioral, and physiologic responses.
    Little JT; Johnson DN; Minichiello M; Weingartner H; Sunderland T
    Neuropsychopharmacology; 1998 Jul; 19(1):60-9. PubMed ID: 9608577
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reversal of mecamylamine-induced effects in healthy subjects by nicotine receptor agonists: Cognitive and (electro) physiological responses.
    Alvarez-Jimenez R; Hart EP; Prins S; de Kam M; van Gerven JMA; Cohen AF; Groeneveld GJ
    Br J Clin Pharmacol; 2018 May; 84(5):888-899. PubMed ID: 29319910
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mecamylamine does not precipitate withdrawal in cigarette smokers.
    Eissenberg T; Griffiths RR; Stitzer ML
    Psychopharmacology (Berl); 1996 Oct; 127(4):328-36. PubMed ID: 8923568
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mecamylamine reduces some EEG effects of nicotine chewing gum in humans.
    Pickworth WB; Herning RI; Henningfield JE
    Pharmacol Biochem Behav; 1988 May; 30(1):149-53. PubMed ID: 3174738
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An EEG nicotinic acetylcholine index to assess the efficacy of pro-cognitive compounds.
    Simpraga S; Mansvelder HD; Groeneveld GJ; Prins S; Hart EP; Poil SS; Linkenkaer-Hansen K
    Clin Neurophysiol; 2018 Nov; 129(11):2325-2332. PubMed ID: 30248622
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Age-related effects of the nicotinic antagonist mecamylamine on cognition and behavior.
    Newhouse PA; Potter A; Corwin J; Lenox R
    Neuropsychopharmacology; 1994 Apr; 10(2):93-107. PubMed ID: 8024677
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mecamylamine acutely increases human intravenous nicotine self-administration.
    Rose JE; Behm FM; Westman EC; Bates JE
    Pharmacol Biochem Behav; 2003 Sep; 76(2):307-13. PubMed ID: 14592683
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A test of the cognitive-enhancing potential of low-dose mecamylamine in healthy non-smokers.
    Yuille MB; Olmstead CK; Wells AK; Hahn B
    Psychopharmacology (Berl); 2017 Jan; 234(1):109-116. PubMed ID: 27678550
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential involvement of glutamatergic mechanisms in the cognitive and subjective effects of smoking.
    Jackson A; Nesic J; Groombridge C; Clowry O; Rusted J; Duka T
    Neuropsychopharmacology; 2009 Jan; 34(2):257-65. PubMed ID: 18418361
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mecamylamine blockade of both positive and negative effects of IV nicotine in human volunteers.
    Lundahl LH; Henningfield JE; Lukas SE
    Pharmacol Biochem Behav; 2000 Jul; 66(3):637-43. PubMed ID: 10899382
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The cholinergic basis of the smoking-induced EEG activation profile.
    Knott VJ; Harr A; Ilivitsky V; Mahoney C
    Neuropsychobiology; 1998; 38(2):97-107. PubMed ID: 9732210
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mecamylamine attenuates cue-induced reinstatement of nicotine-seeking behavior in rats.
    Liu X; Caggiula AR; Yee SK; Nobuta H; Sved AF; Pechnick RN; Poland RE
    Neuropsychopharmacology; 2007 Mar; 32(3):710-8. PubMed ID: 16794568
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of nicotine and mecamylamine on choice accuracy in an operant visual signal detection task in female rats.
    Rezvani AH; Bushnell PJ; Levin ED
    Psychopharmacology (Berl); 2002 Dec; 164(4):369-75. PubMed ID: 12457266
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nicotine-mecamylamine interactions.
    Zevin S; Jacob P; Benowitz NL
    Clin Pharmacol Ther; 2000 Jul; 68(1):58-66. PubMed ID: 10945316
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of the nicotinic antagonist mecamylamine on inspection time.
    Thompson JC; Stough C; Ames D; Ritchie C; Nathan PJ
    Psychopharmacology (Berl); 2000 May; 150(1):117-9. PubMed ID: 10867984
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Behavioral and biochemical manifestations of mecamylamine-precipitated nicotine withdrawal in the rat: role of nicotinic receptors in the ventral tegmental area.
    Hildebrand BE; Panagis G; Svensson TH; Nomikos GG
    Neuropsychopharmacology; 1999 Oct; 21(4):560-74. PubMed ID: 10481840
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bupropion attenuates nicotine abstinence syndrome in the rat.
    Malin DH; Lake JR; Smith TD; Khambati HN; Meyers-Paal RL; Montellano AL; Jennings RE; Erwin DS; Presley SE; Perales BA
    Psychopharmacology (Berl); 2006 Mar; 184(3-4):494-503. PubMed ID: 16163521
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A preliminary study of the effects of cigarette smoking on prepulse inhibition in schizophrenia: involvement of nicotinic receptor mechanisms.
    George TP; Termine A; Sacco KA; Allen TM; Reutenauer E; Vessicchio JC; Duncan EJ
    Schizophr Res; 2006 Oct; 87(1-3):307-15. PubMed ID: 16854565
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.